FDA Approved: ALPRAZOLAM — Supplemental Application (Par Health USA, LLC)

View source ↗

Summary

FDA approved a supplemental Abbreviated New Drug Application for alprazolam, a generic benzodiazepine manufactured by Par Health USA, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Anxiety Disorder
• Panic Disorder

Drugs mentioned

• Alprazolam (alprazolam)

Snippet

SUPPL AP for ALPRAZOLAM (ALPRAZOLAM)